作者
Pang Yao,Andri Iona,Alfred Pozarickij,Saredo Said,Neil Wright,Kuang Lin,Iona Y. Millwood,Hannah Fry,Christiana Kartsonaki,Mohsen Mazidi,Yiping Chen,Fiona Bragg,Bo‐Wen Liu,Ling Yang,Junxi Liu,Daniel Avery,Dan Schmidt,Dianjianyi Sun,Pei Pei,Jun Lv,Canqing Yu,Michael Hill,Derrick Bennett,Robin Walters,Liming Li,Robert Clarke,Huaidong Du,Zhengming Chen
摘要
Integrated analyses of plasma proteomics and genetic data in prospective studies can help assess the causal relevance of proteins, improve risk prediction, and discover novel protein drug targets for type 2 diabetes (T2D).